Literature DB >> 1715462

Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis patients.

M A Saragoça1, M E Canziani, J L Cassiolato, M A Gil, J L Andrade, S A Draibe, E E Martinez.   

Abstract

The contribution of left ventricular hypertrophy in determining ventricular arrhythmias (VAS) was studied in 81 chronic renal failure patients in chronic hemodialysis using two-dimensional echocardiographic and electrocardiogram Holter monitoring. The prevalence of LVH was 93% (96% in hypertensive and 87% in normotensive patients). The prevalence of VA was 48%. These arrhythmias were associated with increased cardiac mass, lack of potassium supplementation to the hemodialysis bath, and low K+ and PaO2 during dialysis. Severe forms of VA occurred in 19 of 78 patients, and the risk factors for this occurrence were (a) largely increased cardiac mass indices (exceeding in more than 40% the upper limit of normal for each sex) and (b) prolonged periods of time in hemodialysis treatment (34 +/- 5.5 vs. 17 +/- 2.7 months, p less than 0.05). Changes in potassium or oxygen content of the blood were not significantly associated with the occurrence of severe forms of VA.

Entities:  

Mesh:

Year:  1991        PMID: 1715462     DOI: 10.1097/00005344-199117002-00032

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  Asymptomatic Ventricular Arrhythmia and Clinical Outcomes in Chronic Kidney Disease: A Pilot Study.

Authors:  Fabiana Oliveira Bastos Bonato; Renato Watanabe; Marcelo Montebello Lemos; José Luiz Cassiolato; Myles Wolf; Maria Eugênia Fernandes Canziani
Journal:  Cardiorenal Med       Date:  2016-10-28       Impact factor: 2.041

Review 2.  Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyperkalemia and hyponatremia.

Authors:  Markus Pirklbauer
Journal:  Hemodial Int       Date:  2020-05-20       Impact factor: 1.812

3.  Calcium dysregulation increases right ventricular outflow tract arrhythmogenesis in rabbit model of chronic kidney disease.

Authors:  Shih-Yu Huang; Yao-Chang Chen; Yu-Hsun Kao; Yen-Yu Lu; Yung-Kuo Lin; Satoshi Higa; Shih-Ann Chen; Yi-Jen Chen
Journal:  J Cell Mol Med       Date:  2021-11-10       Impact factor: 5.310

4.  Prevalence of ventricular arrhythmia and its associated factors in nondialyzed chronic kidney disease patients.

Authors:  Fabiana Oliveira Bastos Bonato; Marcelo Montebello Lemos; José Luiz Cassiolato; Maria Eugênia Fernandes Canziani
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

5.  Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia.

Authors:  Chien-Wei Huang; Min-Jing Lee; Po-Tsang Lee; Chih-Yang Hsu; Wei-Chieh Huang; Chien-Liang Chen; Kang-Ju Chou; Hua-Chang Fang
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

Review 6.  Treatment of Severe Hyperkalemia: Confronting 4 Fallacies.

Authors:  J Gary Abuelo
Journal:  Kidney Int Rep       Date:  2017-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.